Local
Moderna eyes global cancer treatment production in Marlborough
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: Community Advocate

Moderna is based at 149 Hayes Memorial Drive. (Photo/Maureen Sullivan) MARLBOROUGH — Moderna expects its Marlborough facility to become the worldwide production site for an experimental, personalized cancer treatment in 2027, pending regulatory approvals.The company outlined the plans Nov. 12 as part of a presentation to financial analysts. The treatment, called intismeran, is being developed with Merck and has not been approved by the U.S. Food and Drug Administration. The Marlborough facility was built out specifically to manufacture the treatment and began producing material for clinical studies in September 2025. Moderna said the site is preparing to supply the treatment for use outside those studies if regulators approve it. The company said robotics, automated systems and compact manufacturing equipment are designed to speed production and lower costs.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Community Advocate



